13FPulse
中
AU

AURA AURA BIOSCIENCES INC

2026Q2 · CUSIP 05153U107 · Sector: Healthcare & Biotech

Piling in

Net holder growth ranks near the top of the market

Funds that own it
145
Institutions that reported holding it to the SEC
Net increase in holders
+20
Last quarter 125 → now 145
How unusual is that
Top 20%
Stronger buying than 83% of US stocks
What the filings say, in one paragraph

145 funds held AURA at the end of 2026Q2, up 20 from the quarter before. That is stronger buying than 83.1% of US stocks — among the most piled-into names this quarter. On the business itself, return on equity is -41.6%. AURA has had 3 buying rushes in its history, and the price moved -39.1% on average over the six months after (that is the raw price move, not how much it beat the market by). It sits in the Healthcare & Biotech sector.

How many funds owned it, quarter by quarter

Bars = net change in institutional holders, positive (green) or negative (red). Line = total institutional holders.

2022Q1: holders=35 2022Q2: holders=44 2022Q3: holders=43 2022Q4: holders=49 2023Q1: holders=57 2023Q2: holders=59 2023Q3: holders=64 2023Q4: holders=72 2024Q1: holders=78 2024Q2: holders=75 2024Q3: holders=81 2024Q4: holders=94 2025Q1: holders=94 2025Q2: holders=103 2025Q3: holders=105 2025Q4: holders=117 2026Q1: holders=125 2026Q2: holders=145 -20 -10 +0 +10 +20 3192153 22Q122Q323Q123Q324Q124Q325Q125Q326Q126Q2 Net change in holders (bars) Total funds holding (line)

What happened after each past buying rush 3 times in its history

Quarter of the rush How unusual then Price, next 3 months Price, next 6 months
2026Q2 Top 20% — —
2023Q1 Top 20% -12.4% -29.2%
2022Q2 Top 20% -33.1% -49.1%

These are the raw price moves, not how much it beat the market by. Compare them against the market over the same months — in a strong bull market almost everything is up.

Show all the numbers (large funds, value held, options…) ▾
Of them, large funds
75
Change in large funds
+11
Total value they hold
$677M
Funds buying for the first time
38
Funds that sold out entirely
18
Price change that quarter
-0.5%
Funds holding puts (bearish)
2
Funds holding calls (bullish)
1

These are for people who want to dig. Skip them if they do not mean anything to you — the three numbers above are enough.

8,697 institutions have filed for this quarter. 13F permits late filing and a small number arrive in the weeks after the deadline, so the holder counts and changes below may tick up.

Fundamentals

PE (TTM)
—
EPS (TTM)
$-1.72
EPS YoY
—
Revenue (TTM)
—
Revenue YoY
—
Net margin
—
ROE
-41.6%
Debt ratio
9.4%
FCF (TTM)
-$103M
Dividend (TTM)
No dividend
Quarterly Revenue & EPS
2021-09-30: EPS -28.33 2021-12-31: EPS 68.53 2022-03-31: EPS -0.44 2022-06-30: EPS -0.46 2022-09-30: EPS -0.54 2022-12-31: EPS -0.52 2023-03-31: EPS -0.46 2023-06-30: EPS -0.48 2023-09-30: EPS -0.48 2023-12-31: EPS -0.51 2024-03-31: EPS -0.40 2024-06-30: EPS -0.41 2024-09-30: EPS -0.42 2024-12-31: EPS -0.52 2025-03-31: EPS -0.55 2025-06-30: EPS -0.47 2025-09-30: EPS -0.40 2025-12-31: EPS -0.34 2026-03-31: EPS -0.50 2026-06-30: EPS -0.48 -31.16 22.11 75.38 20212022202320242025202606/26 EPS

Quarterly figures, revenue up to 10 years back; EPS split-adjusted, early quarters hidden when not calibrable

P/E (TTM) over time
0 0 1 20222023202420252026

P/E = close around day 47 after quarter-end ÷ TTM EPS then; this is a consistent valuation date, not the company’s actual filing date; loss quarters hidden

Quarterly free cash flow
-30M-15M0K 2020202120222023202420252026
Latest quarter $-30M (2026-03-31)

FCF = operating cash flow − capex, computed from SEC XBRL; banks/insurers have no standard cash-flow structure and are hidden

As of 2026-06-30 · SEC filings (XBRL)

Email me the next update

2026 Q3 holdings are due 2026-11-16. We will email you when the refreshed lists are live.